Prognostic Relevance of Altered pRb and p53 Protein Expression in Surgically Treated Non-Small Cell Lung Cancer Patients

Publisher： Karger

E-ISSN： 1423-0232|67|1|60-66

ISSN： 0030-2414

Source： Oncology, Vol.67, Iss.1, 2004-10, pp. : 60-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of p53 and Glutathione S-Transferase-π Relates to Clinical Drug Resistance in Non-Small Cell Lung Cancer

By  

Oncology, Vol. 57, Iss. 4, 1999-11 ,pp. : 318-323

Karger

Access to resources Recommend Favorite

Prognostic Factors in Elderly Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy

By  

Oncology, Vol. 76, Iss. 5, 2009-03 ,pp. : 355-362

Karger

Access to resources Recommend Favorite

Immunohistochemical Expression and Serum Levels of CD44 as Prognostic Indicators in Patients with Non-Small Cell Lung Cancer

By  

Oncology, Vol. 90, Iss. 6, 2016-05 ,pp. : 327-338

Karger

Access to resources Recommend Favorite

Gefitinib-Induced Hepatotoxicity in Patients Treated for Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 35, Iss. 9, 2012-08 ,pp. : 509-513

Karger

Access to resources Recommend Favorite

Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 92, Iss. 5, 2017-02 ,pp. : 283-290

Karger

Access to resources Recommend Favorite